We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, asset impairments, and related consulting fees. The following reflects our restructuring activity (in millions):


	Three Months Ended
	June 27, 2026
	Supply Chain Reinvention		Project Energize		Nutrition Network Optimization		Operational Enhancement Program		Total
Beginning balance	$	—	$	14.2	$	20.5	$	64.0	$	98.7
Additional charges	1.1		2.6		14.8		(4.1)		14.4
Payments	(1.1)		(10.9)		(5.5)		(17.3)		(34.8)
Non-cash adjustments	—		(0.1)		—		(0.1)		(0.2)
Foreign currency effect	—		0.3		—		(1.7)		(1.4)
Ending balance	$	—	$	6.1	$	29.8	$	40.8	$	76.7


	Six Months Ended
	June 27, 2026
	Supply Chain Reinvention		Project Energize		Nutrition Network Optimization		Operational Enhancement Program		Total
Beginning balance	$	—	$	24.3	$	18.3	$	2.6	$	45.2
Additional charges	1.2		2.3		17.0		69.0		89.5
Payments	(1.2)		(15.5)		(5.5)		(27.9)		(50.1)
Non-cash adjustments	—		(3.3)		—		(1.3)		(4.6)
Foreign currency effect	—		(1.7)		—		(1.6)		(3.3)
Ending balance	$	—	$	6.1	$	29.8	$	40.8	$	76.7


	Three Months Ended
	June 28, 2025
	Supply Chain Reinvention		HRA Pharma Integration		Project Energize		Nutrition Network Optimization		Other Initiatives		Total
Beginning balance	$	0.8	$	1.6	26.7		$	16.5	$	—	$	45.6
Additional charges	2.2		(1.5)		6.8		1.2		—		8.7
Payments	(1.7)		—		(8.5)		—		—		(10.2)
Non-cash adjustments	—		—		(2.8)		—		—		(2.8)
Foreign currency effect	(0.2)		(0.1)		—		—		$	0.3	—
Ending balance	$	1.1	$	—	$	22.2	$	17.7	$	—	$	41.0


	Six Months Ended
	June 28, 2025
	Supply Chain Reinvention		HRA Pharma Integration		Project Energize		Nutrition Network Optimization		Other Initiatives		Total
Beginning balance	$	2.3	$	1.6	$	27.9	$	—	$	1.0	$	32.8
Additional charges	6.8		(1.5)		15.1		17.7		—		38.1
Payments	(8.6)		—		(22.9)		—		(1.0)		(32.5)
Non-cash adjustments	—		—		(2.8)		—		—		(2.8)
Foreign currency effect	0.6		(0.1)		4.9		—		—		5.4
Ending balance	$	1.1	$	—	$	22.2	$	17.7	$	—	$	41.0

The charges incurred during the three months ended June 27, 2026 were primarily associated with employee separation costs as a result of actions taken on Nutrition Network Optimization. The charges incurred during the six months ended June 27, 2026 were primarily associated with employee separation costs as a result of the Operational Enhancement Program. The charges incurred during the three months ended June 28, 2025 were primarily associated with employee separation costs as a result of actions taken on Project Energize. The charges incurred during the six months ended June 28, 2025 were primarily associated with employee separation costs as a result of actions taken on Nutrition Network Optimization and Project Energize.

Of the amount recorded during three months ended June 27, 2026, our Self Care and Specialty Care segments reversed charges in the amounts of $0.8 million and $3.8 million, respectively, due primarily to adjustments to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the six months ended June 27, 2026, our Self Care and Specialty Care segments incurred charges in the amounts of $35.8 million and $8.4 million, respectively, due primarily to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the three and six months ended June 27, 2026, $14.8 million and $22.5 million, respectively, related to our Infant Formula segment, due primarily to Nutrition Network Optimization. Charges totaling $5.0 million and $18.5 million during the three and six months ended June 27, 2026, respectively, primarily for separation costs associated with the Operational Enhancement Program were corporate costs not allocated to a reporting segment.

Of the amount recorded during the three and six months ended June 28, 2025, $3.8 million and $9.1 million, respectively, were related to our Self Care segment, due primarily to Project Energize, and $1.2 million and $3.0 million, respectively, related to our Specialty Care segment, due primarily to Project Energize, and $1.2 million and $17.7 million, respectively, related to our Infant Formula segment, due to Nutrition Network Optimization. Charges totaling $2.5 million and $8.0 million during the three and six months ended June 28, 2025, respectively, primarily for separation costs associated with Project Energize were corporate costs not allocated to a reporting segment.